Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT00220740 ·Status: COMPLETED ·Phase: PHASE3

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

NCT00268788 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT00001287 ·Status: COMPLETED ·Phase: PHASE2

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

NCT01545076 ·Status: COMPLETED ·Phase: PHASE3

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

NCT00004286 ·Status: COMPLETED ·Phase: PHASE3

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06752356 ·Status: RECRUITING ·Phase: PHASE3

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004 ·Status: RECRUITING ·Phase: PHASE3

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

NCT01824251 ·Status: COMPLETED ·Phase: PHASE3

Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

NCT00666263 ·Status: COMPLETED ·Phase: PHASE3

Immunoglobulin Dosage and Administration Form in CIDP and MMN

NCT02111590 ·Status: COMPLETED

Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome

NCT05114941 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies

NCT00001261 ·Status: COMPLETED ·Phase: PHASE2

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

NCT04208828 ·Status: RECRUITING

Rituximab to Treat Neuropathy With Anti-MAG Antibodies

NCT00050245 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Immunoglobulin Therapy in Optic Neuritis

NCT00000117 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis

NCT00306033 ·Status: COMPLETED ·Phase: PHASE3

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

NCT01655394 ·Status: UNKNOWN

A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT02549170 ·Status: COMPLETED ·Phase: PHASE3

IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3

NCT03401073 ·Status: COMPLETED ·Phase: PHASE2

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

NCT04153422 ·Status: RECRUITING ·Phase: PHASE2

Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg

NCT01349270 ·Status: COMPLETED ·Phase: PHASE3

Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

NCT07273903 ·Status: RECRUITING

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

NCT00004682 ·Status: TERMINATED ·Phase: NA

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

NCT06599697 ·Status: RECRUITING ·Phase: PHASE2